©1996 by The American Society for Biochemistry and Molecular Biology, Inc.
Metabolism of Serotonin to N-Acetylserotonin, Melatonin, and 5-Methoxytryptamine in Hamster Skin Culture (*)

(Received for publication, December 29, 1995; and in revised form, February 27, 1996)

Andrzej Slominski (1)(§) James Baker (1) Thomas G. Rosano (1) Lawrence W. Guisti (1) Gennady Ermak (1) Melissa Grande (2) Stephen J. Gaudet (2)

From the  (1)Department of Pathology and Laboratory Medicine, Albany Medical College, Albany, New York 12208 and the (2)Department of Biology, Merrimack College, Boston, Massachusetts 01845

ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
FOOTNOTES
ACKNOWLEDGEMENTS
REFERENCES

ABSTRACT

Biotransformation of [^3H]serotonin by cultured hamster skin to ^3H-metabolites corresponding to N-acetylserotonin (NAS), melatonin, and 5-methoxytryptamine (5-MT) was demonstrated. This process was time-dependent, with the highest production of radioactive NAS and melatonin metabolites after 3 and 5 h of incubation followed by a decrease in the rate of metabolite release into the media. Conversely, the formation of radioactive metabolite corresponding to 5-MT increased gradually during skin culture, reaching the highest level after 24 h of incubation. The production of ^3H-metabolites, corresponding to NAS, melatonin, and 5-MT, was stimulated by forskolin with a maximum effect of forskolin at 10 µM concentration. The gas chromatographic/mass spectroscopy analysis of the fraction eluting at the retention time of NAS standard material showed that it contained NAS, further confirming production and release of NAS into the media by hamster skin. Therefore, we conclude that mammalian skin can acetylate serotonin to NAS and postulate that the NAS is further metabolized by the skin to form melatonin which is subsequently transformed to 5-MT.


INTRODUCTION

Melatonin serves as the main signal molecule which links the photoperiod to metabolic, endocrine, and immunological changes and which is mainly synthesized in the pineal gland, retina, brain, and Harderian gland(1) . Depending of the site of production and target organ it can act as a hormone, neurotransmitter, cytokine, and biological modifier(2) .

Melatonin is a product of a two-step conversion of serotonin, which involves the acetylation of serotonin (3) and subsequent methylation by hydroxyindole-O-methyltransferase(4) . The majority of melatonin released into the bloodstream is metabolized in the liver and kidneys(5, 6) , mainly by 6-hydroxylation and conjugation to glucuronate or sulfate(5, 6) , and to a minor degree by deacetylation to 5-methoxytryptamine (5-MT), (^1)which is further deaminated(5, 6, 7) . In contrast, melatonin bioconversion at the organ site of synthesis appears to be different from the metabolism of circulating melatonin(8, 9, 10) . For example, in the retina melatonin is first deacetylated to 5-MT, which can then be deaminated, producing 5-methoxyindoleacetic acid and 5-methoxytryptophol(8, 9) . Melatonin deacetylation to 5-MT was also detected in retinal pigment epithelium and non-mammalian skin that are target sites for melatonin bioregulation(8, 9, 10) . Extracranial sites of both synthesis and metabolism of melatonin have also been demonstrated in the peripheral blood mononuclear leukocytes(11) , and according to some authors in the gastrointestinal tract(12) .

Melatonin production has not previously been demonstrated in skin, which is the largest body organ that can react to external and internal stimuli via the skin immune system(13) , the pigmentary system(14) , and the skin endocrine system(15, 16) . In lower verterbrates skin is a recognized target for melatonin action, e.g. melatonin has lightening activity on the skin(17) . In mammals, it has been reported that melatonin can regulate hair growth(18) , inhibit follicular melanogenesis(19, 20) , and affect proliferation of epidermal keratinocytes (20) and malignant melanocytes(21) . Specific binding sites for melatonin were also detected in the mammalian skin(20) . In addition, we have identified two isozymic forms of arylamine N-acetyltransferase, NAT-1 and NAT-2, in hamster skin of which NAT-2 catalyzed the acetylation of dopamine to N-acetyldopamine and serotonin to NAS, a direct precursor of melatonin(22) . This information has formed the basis for the present studies on the synthesis and degradation of melatonin by mammalian skin.


MATERIALS AND METHODS

Animals and Skin Culture

Three-month-old male Syrian golden hamsters (Mesocricetus aureatus) were purchased from Charles River Laboratory, Wilmington, MA, housed in community cages with 12-h light periods, and fed ad libitum with water and rat/mouse chow. The animals were sacrificed, hair shafts were removed with an electrical animal clipper, the skin was dissected at the level of of subcutis, and punch biopsies of skin were used for short-term skin culture as described previously(20) . The incubations were started between 6 and 7 p.m. Three to five punch biopsies of skin per group were incubated together at the air-liquid interphase in 300 µl of medium (Dulbecco's modified Eagle's medium + 10% fetal bovine serum and 1% antibiotic/antimycotic mixture, all from Life Technologies, Inc.) in 24-well plates at 37 °C, 5% CO(2) in air and 100% humidity for 3, 5, 6, 12, 14, and 24 h. Four-mm punch biopsies were used throughout the study in order to standarize the tissue volume and thereby the cell mass in each fragment. In control experiments we used primary cell culture of hamster amelanotic melanoma cells (23) .

[^3H]Thymidine Incorporation

To measure DNA synthesis (20) skin cultures were pulsed with 1 µCi/ml [^3H]thymidine and, after defined periods of incubation, washed with phosphate-buffered saline and incubated 3 times for 30 min with continuous shaking in 2 M NaBr to remove nonincorporated thymidine(20) . The amount of [^3H]thymidine incorporated into each fragment was measured separately by liquid scintillation spectrometry (20) and expressed as the mean cpm (± S.E.) per skin biopsy.

Melatonin Synthesis

To study melatonin synthesis, 1, 5, or 10 µCi of [^3H]serotonin/ml (DuPont) was added at 7 p.m. to the media and skin cultures were incubated in the presence or absence of forskolin at the concentrations listed. The media and skin were collected and processed separately. The media was extracted with chloroform (Sigma). Chloroform and aqueous phases were further separated by centrifugation in Microfuge at 16,000 times g. Both fractions were collected separately, centrifuged again to remove any impurities, and subjected to analysis by reverse-phase high-performance liquid chromatography (RP-HPLC) analyses. Skin fragments from each culture were homogenized together in 0.1 M sodium phosphate buffer, pH 6.8, plus 1% Triton X-100, followed by centrifugation at 10,000 times g for 15 min at 4 °C. Supernatants were then extracted in chloroform and processed as described above for media samples.

RP-HPLC Analyses

Approximately a 100-µl sample of the tested fraction was injected onto the RP-HPLC column (Versapack C18 1OU, Alltech, Deerfield, IL), which was equilibrated using 0.1 N acetic acid (pH 4.0, flow rate = 1 ml/min). The elution was 0-10 min with acetic acid, 10-50 min with increased methanol from 0 to 100% and 50-60 min with a decreased methanol from 100 to 0% and was monitored at 280 nm using a UV detector. Starting at 20 min, elution fractions of 0.3-ml volume were collected. Each fraction was analyzed by liquid scintillation spectroscopy. During each separation via RP-HPLC of radiolabeled samples nonradioactive standards of serotonin, N-acetylserotonin (NAS), melatonin, and 5-MT (all from Sigma) were included and their retention was determined with ultraviolet detection at 280 nm.

Gas Chromatographic/Mass Spectroscopy (GC/MS)

GC/MS analysis of serotonin, NAS, 5-MT, and melatonin in HPLC eluted fractions was performed with a Perkin-Elmer GC/MS system that included a Model 8420 capillary gas chromatograph with an open-split interface to an ion-trap mass spectrometer. A (5-phenyl)-methylpolysiloxane capillary column (DB-5Ms, 15 m times 25-mm inner diameter) with a film thickness of 0.25 µm (J & W Scientific) was used. Helium was used as the carrier gas with a flow rate of 1 ml/min. A sample injection volume of 1 µl was used in the splitless mode. A column temperature program (100-300 °C, 20 °C/min) with a final hold of 5 min was used along with a column temperature of 250 °C and an ion source temperature of 275 °C. For electron impact ionization (EI), a mass spectral scan from 50 to 500 m/z was employed for full scan studies. In order to enhance sensitivity for detection of NAS EI with selective ion monitoring of ions with m/z 290, 303, and 362 was performed. Molecular weight determination of an unidentified compound with HPLC elution between serotonin and NAS was evaluated by chemical ionization (CI) employing methane gas and mass spectral scan of 50-500 m/z. Ion trap control, data aquisition, and analysis were performed with ITDS for Ion Trap Data System 4.1 (Perkin-Elmer).

Preparation of HPLC fractions for GC/MS analysis was performed by initial drying of fraction samples. The dry residue was reconstituted with 1 ml of methanol, vortex mixed for 30 s, and transferred to a glass conical reaction vial. The samples were then evaporated to dryness and reconstituted with 25 µl of ethyl acetate and vortex mixed. For analysis of 5-MT and melatonin, 1 µl of an ethyl acetate reconstituted sample was used for analysis by GC/MS. For analysis of serotonin, NAS, and an unidentified peak, precolumn derivatization was performed by addition of N-methyl-trimethylsilyltrifluoroacetamide (Regis Chemical Co., Morton Grove, IL) to the ethyl acetate reconstituted sample and incubated at 90 °C for 20 min, followed by GC/MS analysis.

For GC/MS identification of NAS in skin culture, biopsies were incubated for 12-14 h in the presence of 10 µM unlabeled serotonin. The media were extracted with chloroform, and the aqueous phase was analyzed by RP-HPLC as described above. Selected HPLC fractions were then analyzed by GC/MS using selective ion monitoring technique.


RESULTS

RP-HPLC Identification of Tritiated NAS, Melatonin, and 5-MT

To study the possible transformation of serotonin to melatonin by mammalian skin and further metabolism to 5-MT we used short-term skin culture system(20) . Under the conditions tested, the hamster skin remained viable and metabolically active for at least 24 h of incubation as evidenced by progressive increase in DNA synthesis throughout the incubation period (Fig. 1).


Figure 1: Time-dependent DNA synthesis in hamster skin cultured in vitro.



After metabolic labeling with [^3H]serotonin, the media and skin biopsies were prepared separately using chloroform extraction. Both chloroform and aqueous fractions were analyzed by RP-HPLC in the presence of nonradioactive serotonin, NAT, 5-MT, and melatonin standards. Fig. 2shows representative elution times of tritriated serotonin metabolites released into the media after 5 h incubation in the presence of 5 µCi of [^3H]serotonin. The radioactive peaks with retention times corresponding to those of unlabeled standards of NAS (28 min), 5-MT (32 min), and melatonin (36 min) were identified in chloroform extracts (Fig. 2A). HPLC analysis of the aqueous fraction from the same experiment showed the presence of a major radioactive peak corresponding to serotonin, the presence of a radioactive peak corresponding to NAS and the absence of radioactive peaks at the elution time of 5-MT and melatonin (Fig. 2B). The specificity of these findings were further confirmed by the absence of radioactive peaks of NAS, 5-MT, and melatonin in control media from primary cell culture of hamster amelanotic melanoma cells radiolabeled with 5 µCi of [^3H]serotonin (not shown).


Figure 2: RP-HPLC analysis of [^3H]serotonin metabolites produced by hamster skin and released into culture medium. Skin biopsies were incubated for 5 h in the medium containing 5 µCi of [^3H]serotonin and 10 µM forskolin (A and B). The media were chloroform extracted and chloroform (A) and aqueous (B) phases were separated by RP-HPLC in the presence of nonradioactive standards (see below), and the radioactivity in collected fractions was measured by liquid scintillation spectroscopy. SER, NAS, 5-MT, and MEL show radioactive peaks coeluting with unlabeled standards of serotonin, N-acetylserotonin, 5-methoxytryptamine, and melatonin, respectively.



The nature of the other radioactive peaks, including peaks eluting between NAS and 5-MT (30-31 min) and the major hydrophobic peak eluting at 40-42 min has not been determined. The GC/MS characteristic of the peak eluting at 26 min between serotonin and NAS is provided below. We have also attempted to characterize the 40-42-min hydrophobic peak using media from the culture performed in the presence of 100 µM unlabeled serotonin. Preliminary IR-mass spectroscopy suggests a nonaromatic compound (data not shown). This peak was also present in control medium (not shown) despite an absence of detectable transformation of serotonin into melatonin. We suggest that this peak may be unrelated to synthesis and degradation of melatonin and, therefore, we have narrowed our HPLC analyses to elution times of the serotonin, NAS, 5-MT, and melatonin standards.

The spectrum of the RP-HPLC separation of skin extracts was similar to that obtained from culture media. The NAS, 5-MT, and melatonin peaks were present in the chloroform fraction, while the majority of the radioactivity corresponding to serotonin and NAS remained in the aqueous fraction (Fig. 3). Comparison of Fig. 2and Fig. 3shows that the serotonin metabolites accumulate predominantly in the culture media.


Figure 3: RP-HPLC analysis of [^3H]serotonin metabolites accumulating in the hamster skin cultured in vitro. Skin biopsies were incubated for 5 h in the medium containing 5 µCi of [^3H]serotonin and 10 µM forskolin. The skin biopsies were homogenized, centrifuged, and supernatant was chloroform extracted. Chloroform (A) and aqueous (B) phases were separated in the presence of nonradioactive standards as described in the legend to Fig. 2. SER, NAS, 5-MT, and MEL show radioactive peaks coeluting with unlabeled standards of serotonin, N-acetylserotonin, 5-methoxytryptamine, and melatonin, respectively.



GC/MS Identification of NAS

GC/MS analysis of fractions obtained from the HPLC analysis of nonradioactive standard confirmed the identity and retention of serotonin, NAS, melatonin, and 5-MT (data not shown). To analyze culture media an incubation time of 12-14 h was chosen, when appreciable production of [^3H]NAS was evident (Fig. 4). For GC/MS analyses, skin biopsies were incubated in the presence of 10 µM unlabeled serotonin and media were fractionated into chloroform and aqueous fractions which were separated by RP-HPLC. RP-HPLC results indicated that greater than 80% of NAS still remained in the aqueous phase and that less than 10% of the NAS is transformed into melatonin or 5-MT (Fig. 4). We, therefore, focused our GC/MS analysis on the aqueous fractions with retention times corresponding to serotonin and NAS.


Figure 4: Production of identified by RP-HPLC [^3H]N-acetylserotonin, [^3H]melatonin, and [^3H]5-methoxytryptamine by hamster skin cultured in vitro for 12 h. Skin biopsies were incubated in the medium containing 10 µCi of [^3H]serotonin and 10 µM forskolin. The media were extracted and chloroform (A) and aqueous (B) phases were separated by RP-HPLC in the presence of nonradioactive N-acetylserotonin, 5-methoxytryptamine, and melatonin (MEL).



For GC/MS identification of NAS in skin culture media, an analysis of ion fragments resulting from EI analysis of purified NAS was initially performed. Fig. 5A shows a total ion count chromatograph of a standard preparation of NAS which was derivatized and chromatographed. The mass spectra insert shows ion fragments with m/z 73, 290 (base peak), 303, 362, and 435. A proposed structure of the ion fragments is shown, along with the mass spectra, in Fig. 5B. The fragmentation pattern indicates a molecular ion with trisilylated derivatization. The major ion fragment with m/z 290 results from ion impact fragmentation of the carbon-carbon bond in the alkyl side chain of the indole ring, leaving a disilylated fragment ion. The ion with m/z 303 is consistent with the loss of silylated N-acetyl group. A minor abundance of a mono-desilated ion fragment with m/z 362 is also observed with the corresponding trimethyl silyl ion fragment at m/z 73. Ions with m/z 434 and 435 are consistent with the trisilylated molecular ion and its proteinated form, respectively.


Figure 5: GC/MS identification of NAS. A, total ion count chromatogram and partial mass spectrum of N-acetylserotonin standard material. B, mass spectrum with proposed ion fragment structures for N-acetylserotonin. C, GC/MS analysis of HPLC fraction eluting at 27-29 min by selective ion monitoring. The upper and middle panels show selective ion chromatograms for the m/z range of 290 to 303 and 290 to 362, respectively. The lower panel shows the relative abundance of ions with m/z 290, 303, and 362 for the compound with a chromatographic retention time of 10 min 53 s. D, GC/MS analysis of N-acetylserotonin by selective ion monitoring. The upper and middle panels show selective ion chromatography for the m/z range of 290 to 303 and 290 to 362, respectively. The lower panels shows the relative abundance on ions with m/z 290, 303, and 362 for the compound with a chromatographic retention time of 10 min 53 s.



Based on the mass spectrum analysis of NAS, ions with m/z 290, 303, and 362 were used in the GC/MS identification of NAS in the aqueous layer of the media from skin culture. Results of the GC/MS analysis of the RP-HPLC fraction eluting at 27-29 min are shown in Fig. 5C. The upper and middle panels show selective ion chromatograms for the m/z range of 290 to 303 and 290 to 362, respectively. Both chromatograms show a single peak eluting at a retention time consistent with NAS. In the lower panel is shown the relative abundance of ions with m/z 290, 303, and 362. Fig. 5D shows a parallel GC/MS analysis of pure NAS. The relative abundance of fragment ions with m/z 290, 303, and 362 shown in the lower panel of Fig. 5, C and D, evidence a close agreement of ion ratios for pure NAS and the compound isolated from skin culture media. Thus, the compound isolated from the skin culture media is identified as NAS based upon HPLC retention, gas chromatographic retention, and mass spectral fragmentation ions.

Furthermore, we analyzed from aqueous phase the RP-HPLC fraction eluting at 25-26 min, which corresponds to the second major radioactive peak eluting between serotonin and NAS (Fig. 2Fig. 3Fig. 4). The analysis was performed by EI and CI modes. The major compound in this fraction has a gas chromatographic retention time of 11 min 48 s. The EI mass spectrum resulted in ion fragments with m/z 73, 354, 410, and 426 (base peak). The ion with m/z 426 also predominated in the CI analysis. Although we do not yet have the structural identity of this compound, we propose that it is a product of serotonin metabolism with a molecular weight of 425 daltons for the derivatized compound. The mass spectrum of the unknown compound was not consistent with the structures of 5-hydroxyindole acetaldehyde, 5-hydroxytryptophol, 5-hydroxyindole acetic acid, 5-methoxytryptophol, and 5-methoxyindoleacetic acid.

Time-dependent Metabolism of Serotonin and the Stimulatory Effect of Forskolin

To study time-dependent changes in transformation of serotonin to melatonin and further to 5-MT as well as the effect of forskolin (10 µM) on this process, media, after different times of incubation, were chloroform fractionated and separated by RP-HPLC (Fig. 6). The representative HPLC elution characteristics after 3, 5, and 24 h of incubation are shown in Fig. 6A-C, respectively, and panel D (summary panel) shows the levels of tritriated metabolites fractionated into the chloroform phase. The highest production of [^3H]NAS and [^3H]melatonin occurred between 3 and 5 h of incubation, which corresponded to 10 and 12 p.m., and then decreased with the lowest level observed at the 24 h of incubation (Fig. 6D). Conversely, the production of [^3H]5-MT increased progressively during the time of incubation reaching the highest values at 24 h (Fig. 6, C and D).


Figure 6: Time-dependent production of [^3H]N-acetylserotonin, [^3H]melatonin, and [^3H]5-methoxytryptamine by hamster skin. Skin biopsies were incubated in the medium containing 10 µCi of [^3H]serotonin. After defined time periods cultures were terminated, media were extracted, and chloroform phases were separated by RP-HPLC in the presence of nonradioactive standards of serotonin (SER), NAS, 5-MT, and melatonin (MEL). The results are the summary of two skin cultures. A, 3 h of incubation; B, 5 h of incubation; C, 24 h of incubation; D, summary panel.



The data from representative RP-HPLC separations performed on the chloroform phase obtained after 6 h of incubation in the absence or presence of 1, 10, and 100 µM forskolin are presented in Fig. 7, A-E. The addition of forskolin stimulated production of tritiated NAS, melatonin, and 5-MT in a dose-dependent manner with a maximal stimulation at 10 µM concentration (Fig. 7C). In a separate experiment we analyzed the aqueous fraction by a RP-HPLC. It appeared that the NAS concentration in the aqueous fraction was higher in the presence of 10 µM forskolin than in control (not shown), which is consistent with the data presented in Fig. 7.


Figure 7: The effect of forskolin on production of [^3H]N-acetylserotonin, [^3H]melatonin, and [^3H]5-methoxytryptamine by hamster skin. Skin biopsies were incubated for 6 h in the medium containing 10 µCi of [^3H]serotonin and different concentrations of forskolin: none (A, control), 1 µM (B), 10 µM (C), 100 µM (D), summary panel (E). Chloroform phases of the culture media from 2 skin cultures were separated by RP-HPLC in the presence of nonradioactive standards of serotonin (SER), NAS, 5-MT, and melatonin (MEL).




DISCUSSION

In previous studies with hamster skin, we have identified and characterized the NAT-2 isozymic form of arylamine N-acetyltransferase that catalyzed the acetylation of serotonin to NAS, a direct precursor of melatonin, thus suggesting a non-rhythmic formation of N-acetylserotonin(22) . We now have direct experimental evidence showing that mammalian skin can transform [^3H]serotonin to radioactive metabolites eluting at the same time as noradioactive NAS, melatonin, and 5-MT standards. The GC/MS confirmed that coeluting nonradioactive standards separated by RP-HPLC were serotonin, NAS, melatonin, and 5-MT. Furthermore, the GC/MS analysis of the fraction eluting at the same time as NAS confirms the presence of NAS. Therefore, we conclude that mammalian skin in vivo can transform serotonin into NAS. Moreover, on the basis of RP-HPLC separation data we postulate that in the skin the NAS is further transformed to melatonin and suggest that it is subsequently deacetylated to 5-MT analogous to the metabolic pathway in the retina(8, 9, 10) .

According to our estimation, the production of NAS is comparatively higher than its further transformation to melatonin, i.e. approximately 1-2% of [^3H]serotonin added is transformed to [^3H]NAS, of which less than 10% is metabolized further to [^3H]melatonin and [^3H]5-MT. This may be explained by a lower efficiency of the hydroxyindole-O-methyltransferase in transforming NAS to melatonin and by existence of an alternative pathway directly metabolizing NAS. The rate at which hydroxyindole-O-methyltransferase changes in response to stimuli is relatively slow as compared to that of the arylalkylamine NAT(24, 25) .

In the pineal gland and retina the generation of melatonin production exhibits a circadian rhythm with the peak activity at night(1, 2) . This process is accompanied by an increased activity of the rate-limiting enzyme in melatonin synthesis, arylalkylamine NAT that acetylates serotonin to NAS(1, 2, 3) . These processes are stimulated by the rise in the intracellular concentrations of cAMP(1, 2, 3) . It is of interest that in skin culture the highest production of [^3H]NAS and [^3H]melatonin was observed at 10 and 12 p.m. and that this process appeared to be stimulated by forskolin (stimulator of intracellular cAMP accumulation(1, 2, 3, 4) ). Therefore, it is possible that a mechanism governing cutaneous production of NAS and melatonin may be similar to that operating in the pineal gland and retina. This requires further study.

In non-mammalian vertebrates, degradation of melatonin at the site of its action such as retinal pigment epithelium and skin, or at site of its extrapineal production, retina, occurred predominatly via melatonin deacetylation to 5-MT(8, 9, 10) . In the present study we show the gradual increase of [^3H]5-MT during skin culture, which reached its highest level after 24 h of incubation, and which was accompanied by a decrease in [^3H]NAS and [^3H]melatonin concentration. Furthermore, it was reported previously that rodent skin is a site for melatonin bioregulation(20) . Based on this information and the data presented above we suggest that rodent skin, similar to non-mammalian skin and retina(8, 9, 10) , deacetylates melatonin to 5-MT in order to terminate its action or to generate methoxyindoles with a potential local biological activity.

Previously Finocchiaro et al.(11) showed melatonin biosynthesis and metabolism in peripheral blood leukocytes, while Huether et al.(12) have suggested a possible melatonin synthesis in the gut. This last finding, however, was disputed by others(26) . Presented here are data supporting the concept that there are extracranial and peripherially located sites of melatonin synthesis (11) . Since the integumentum has the same embryonal origin as the central nervous system(27) , it is not surprising that skin is capable of producing neurohormones and expressing corresponding receptors(15, 28) . Skin is composed of many unrelated cells of neuroectodermal and mesenchymal origin including melanocytes, Merkel cells, keratinocytes, resident, and circulating immune response associated cells, fibroblasts, endothelial cells, and fat cells(13, 16, 18, 27) . Future experiments with in situ hybridization techniques using molecular probes from the recently cloned gene coding arylalkylamine NAT (29, 30) may help identify cutaneous cells producing melatonin and may better define the role of melatonin in skin function.

In conclusion, we show that the mammalian skin can produce NAS, melatonin, and 5-MT and suggest that production of 5-MT may represent a local mechanism of melatonin inactivation. Thus, the skin appears to be both a target for melatonin bioregulation and a site of its synthesis and degradation.


FOOTNOTES

*
The project was supported by a Mary Kay/Dermatology Foundation Research Grant (to A. S.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore by hereby marked ``advertisement'' in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

§
To whom correspondence should be addressed: Dept. of Pathology, 47 New Scotland Ave., Albany Medical College, Albany, NY 12208. Tel.: 518-262-5499; Fax: 518-262-5927.

(^1)
The abbreviations used are: 5-MT, 5-methoxytryptamine; NAS, N-acetylserotonin; NAT, N-acetyltransferase; RP-HPLC, reverse-phase-high performance liquid chromatography; GC/MS, gas chromatographic/mass spectroscopy; EI, electron impact; CI, chemical ionization.


ACKNOWLEDGEMENTS

We acknowledge the generous support of Dr. Mihm and critical reading of the manuscript by Dr. A. Namboodiri.


REFERENCES

  1. Yu, H.-S., and Reiter, R. J. (1993) Melatonin Biosynthesis, Physiological Effects and Clinical Implications, CRC Press, Boca Raton, FL
  2. Reiter, R. J. (1991) Endocr. Rev. 12, 151-180 [Medline] [Order article via Infotrieve]
  3. Namboodiri, M. A. A., Dubbels, R., and Klein, D. C. (1987) Methods Enzymol. 142, 583-590 [Medline] [Order article via Infotrieve]
  4. Sugden, D., Cena, V., and Klein, D. C. (1987) Methods Enzymol. 142, 590-596 [Medline] [Order article via Infotrieve]
  5. Kopin, I. J., Pare, C. M. B., Axelrod, J., and Weissbach, H. (1961) J. Biol. Chem. 236, 3072-3075 [Medline] [Order article via Infotrieve]
  6. Kveder, S., and McIsaac, W. M. (1961) J. Biol. Chem. 236, 3214-3220 [Medline] [Order article via Infotrieve]
  7. Rogawski, M. A., Roth, R. H., and Aghajanian, G. K. (1979) J. Neurochem. 32, 1219-1226 [Medline] [Order article via Infotrieve]
  8. Cahill, G. M., and Besharse, J. C. (1989) Proc. Natl. Acad. Sci. U. S. A. 86, 1098-1102 [Abstract]
  9. Grace, M. S., Cahill, G. M., and Besharse, J. C. (1991) Brain Res. 559, 56-63 [Medline] [Order article via Infotrieve]
  10. Grace, M. S., and Besharse, J. C. (1993) J. Neurochem. 60, 990-999 [Medline] [Order article via Infotrieve]
  11. Finocchiaro, L. M. E., Nahmod, V. E., and Launay, J. M. (1991) Biochem. J. 280, 727-731 [Medline] [Order article via Infotrieve]
  12. Huether, G., Poeggler, B., Reimer, A., and George, A. (1992) Life Sci. 51, 945-953 [CrossRef][Medline] [Order article via Infotrieve]
  13. Bos, J. D. (1990) Skin Immune System (SIS), CRC Press, Boca Raton, FL
  14. Slominski, A., Paus, R., and Schaderdorf, D. (1993) J. Theor. Biol. 164, 103-120 [CrossRef][Medline] [Order article via Infotrieve]
  15. Slominski, A., Paus, R., and Wortsman, J. (1993) Mol. Cell. Endocrinol. 93, C1-C6 [Medline] [Order article via Infotrieve]
  16. Milstone, L. M., and Edelson, R. L. (1988) Ann. N. Y. Acad. Sci. 548, 1-366
  17. Hadley, M. (1988) Endocrinology, Prentice Hall, Englewood Cliffs, NJ
  18. Champion, R. H., Burton, J. L., and Ebling, F. J. O. (1990) Textbook of Dermatology, 5th Ed., Backwell, Oxford
  19. Logan, A., and Weatherhead, B. (1980) J. Invest. Dermatol. 74, 47-50 [Abstract]
  20. Slominski, A., Chassalevris, N., Mazurkiewicz, J., Maurer, M., and Paus, R. (1994) Exp. Dermatol. 3, 45-50 [Medline] [Order article via Infotrieve]
  21. Slominski, A., and Pruski, D. (1993) Exp. Cell Res. 206, 189-194 [CrossRef][Medline] [Order article via Infotrieve]
  22. Gaudet, S., Slominski, A., Etminan, M., Pruski, D., Paus, R., and Namboodiri, M. A. A. (1993) J. Invest. Dermatol. 101, 660-665 [Abstract]
  23. Slominski, A., Moellmann, G., Kuklinska, E., Bomirski, A., and Pawelek, J. (1988) J. Cell Sci. 89, 287-296 [Abstract]
  24. Binkley, S., Macbride, S. E., Klein, D. C., and Ralph, C. L. (1975) Endocrinology 96, 848-853 [Abstract]
  25. Klein, D. C., and Moore, R. Y. (1979) Brain Res. 174, 245-262 [CrossRef][Medline] [Order article via Infotrieve]
  26. Brammer, G. (1994) Life Sci. 55, 775-787 [Medline] [Order article via Infotrieve]
  27. Gilbert, S. F. (1988) Developmental Biology, Sinauer Associates, Sunderland, MA
  28. Slominski, A., Ermak, G., Hwang, J., Chakraborty, A., Mazurkiewicz, J., and Mihm, M. (1995) FEBS Lett. 374, 113-116 [CrossRef][Medline] [Order article via Infotrieve]
  29. Coon, S. L., Roseboom, P. H., Baler, R., Weller, J. L., Namboodiri, M. A. A., Koonin, E. V., and Klein, D. C. (1995) Science 270, 1681-1683 [Abstract]
  30. Borjigin, J., Wang, M. M., and Snyder, S. H. (1995) Nature 378, 783-785 [CrossRef][Medline] [Order article via Infotrieve]

©1996 by The American Society for Biochemistry and Molecular Biology, Inc.